Immunomodulation in Cystic Fibrosis: Why and How?

Immunomodulation in Cystic Fibrosis: Why and How?

Cystic fibrosis (CF) lung disease is characterized by unconventional mechanisms of inflammation, implicating a chronic immune response dominated by innate immune cells. Historically, therapeutic development has focused on the mutated cystic fibrosis transmembrane conductance regulator (CFTR), leadin...

Full description

Bibliographic Details
Main Authors: Vincent D. Giacalone, Brian S. Dobosh, Amit Gaggar, Rabindra Tirouvanziam, Camilla Margaroli
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
Cystic fibrosis
inflammation
immunotherapy
lung disease
proteases
Online Access:https://www.mdpi.com/1422-0067/21/9/3331

Internet

https://www.mdpi.com/1422-0067/21/9/3331

Similar Items